(RTTNews) - Taro Pharmaceuticals U.S.A., Inc. has recalled one lot of corticosteroid Clobetasol Propionate in the form of ointment for the potential presence of Ralstonia pickettii bacteria, the U.S.

Clobetasol is a prescription drug. It comes as a topical cream, lotion, spray, solution, foam, ointment, and gel. It also comes as a shampoo. Clobetasol topical cream comes in two forms: regular cream ...

HYDERABAD, India & PRINCETON, N.J. & MALVERN, Pa.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), through its wholly owned ...

CORAL GABLES, Fla.--(BUSINESS WIRE)--Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology, today announced that the U.S. Food and Drug ...

New Delhi, Oct 17 (PTI) Drug firm Zydus Cadila Wednesday said it has received final nod from the US health regulator to market generic Clobetasol Propionate cream, used to treat various skin disorders ...

To date, the Company has not received reports of adverse events related to this recall. Taro Pharmaceuticals has issued a voluntary recall of 1 lot of Clobetasol Propionate Ointment USP, 0.05%, 60g ...

BUENA, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's ...

Dr. Reddy’s Laboratories announced that the Food and Drug Administration (FDA) has approved Impoyz (clobetasol propionate) Cream 0.025%, formerly DFD-06, for the treatment of moderate to severe plaque ...

New Delhi, Feb 1 (PTI) Drug firm Lupin today said it has received final nod from the US health regulator to market its Clobetasol Propionate cream used for the treatment of various skin conditions.

Taro Pharmaceuticals U.S.A., Inc. (“Taro” or the “Company”) is voluntarily recalling one (1) lot of Clobetasol Propionate Ointment USP, 0.05% packaged in 60 g tubes, to the consumer level. This recall ...

New Delhi, Mar 5 () Drug firm Alembic Pharmaceuticals Tuesday said its joint venture firm Aleor Dermaceuticals has received approval from the US health regulator for its generic Clobetasol Propionate ...

BUENA, N.J., Aug. 22, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s ...